Search Count: 132
 |
Discovery Of An Orally Bioavailable Reversible Covalent Sars-Cov-2 Mpro Inhibitor With Pan-Coronavirus Activity
Organism: Severe acute respiratory syndrome coronavirus 2, Synthetic construct
Method: X-RAY DIFFRACTION Release Date: 2025-08-20 Classification: HYDROLASE/INHIBOTOR Ligands: A1L7M |
 |
Discovery Of An Orally Bioavailable Reversible Covalent Sars-Cov-2 Mpro Inhibitor With Pan-Coronavirus Activity
Organism: Severe acute respiratory syndrome coronavirus 2, Synthetic construct
Method: X-RAY DIFFRACTION Release Date: 2025-08-20 Classification: HYDROLASE/INHIBITOR |
 |
Discovery Of An Orally Bioavailable Reversible Covalent Sars-Cov-2 Mpro Inhibitor With Pan-Coronavirus Activity
Organism: Severe acute respiratory syndrome coronavirus 2, Synthetic construct
Method: X-RAY DIFFRACTION Release Date: 2025-08-20 Classification: HYDROLASE/INHIBITOR |
 |
Discovery Of An Orally Bioavailable Reversible Covalent Sars-Cov-2 Mpro Inhibitor With Pan-Coronavirus Activity
Organism: Severe acute respiratory syndrome coronavirus 2, Synthetic construct
Method: X-RAY DIFFRACTION Release Date: 2025-08-20 Classification: HYDROLASE/INHIBITOR Ligands: A1L7M |
 |
Discovery Of An Orally Bioavailable Reversible Covalent Sars-Cov-2 Mpro Inhibitor With Pan-Coronavirus Activity
Organism: Severe acute respiratory syndrome coronavirus 2, Synthetic construct
Method: X-RAY DIFFRACTION Release Date: 2025-08-20 Classification: HYDROLASE/INHIBITOR Ligands: A1L7M |
 |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.76 Å Release Date: 2025-04-16 Classification: DNA BINDING PROTEIN/DNA Ligands: CA |
 |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.74 Å Release Date: 2025-04-16 Classification: DNA BINDING PROTEIN/DNA |
 |
Organism: Escherichia coli
Method: ELECTRON MICROSCOPY Release Date: 2025-02-12 Classification: FLAVOPROTEIN Ligands: FAD, FMN, PO4, K, SF4, SRM |
 |
Organism: Thermochaetoides thermophila
Method: ELECTRON MICROSCOPY Release Date: 2024-11-27 Classification: MEMBRANE PROTEIN Ligands: MG |
 |
Organism: Thermochaetoides thermophila
Method: ELECTRON MICROSCOPY Release Date: 2024-11-27 Classification: MEMBRANE PROTEIN Ligands: LOP, MG |
 |
Organism: Homo sapiens, Synthetic construct
Method: X-RAY DIFFRACTION Resolution:2.69 Å Release Date: 2024-09-25 Classification: LIGASE/DNA Ligands: AMP |
 |
Organism: Homo sapiens, Synthetic construct
Method: X-RAY DIFFRACTION Resolution:2.40 Å Release Date: 2024-09-25 Classification: Ligase/DNA Ligands: AMP |
 |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.91 Å Release Date: 2024-09-04 Classification: ANTIBIOTIC Ligands: MYR, A1AZR |
 |
Organism: Acinetobacter baumannii
Method: X-RAY DIFFRACTION Resolution:2.80 Å Release Date: 2024-09-04 Classification: ANTIBIOTIC Ligands: ANP, MVC, MG, A1AZS |
 |
Organism: Homo sapiens, Synthetic construct
Method: X-RAY DIFFRACTION Resolution:2.39 Å Release Date: 2024-05-22 Classification: Ligase/DNA Ligands: AMP |
 |
Organism: Homo sapiens, Synthetic construct
Method: X-RAY DIFFRACTION Resolution:2.79 Å Release Date: 2024-05-22 Classification: Ligase/DNA |
 |
Organism: Homo sapiens, Synthetic construct
Method: X-RAY DIFFRACTION Resolution:2.78 Å Release Date: 2024-05-22 Classification: Ligase/DNA Ligands: PO4 |
 |
Organism: Homo sapiens, Synthetic construct
Method: X-RAY DIFFRACTION Resolution:2.41 Å Release Date: 2024-05-22 Classification: Ligase/DNA Ligands: AMP |
 |
Organism: Homo sapiens, Synthetic construct
Method: X-RAY DIFFRACTION Resolution:2.51 Å Release Date: 2024-05-22 Classification: Ligase/DNA Ligands: AMP |
 |
Organism: Acinetobacter baumannii
Method: ELECTRON MICROSCOPY Release Date: 2024-04-24 Classification: ANTIMICROBIAL PROTEIN Ligands: ANP, ZQF |